Austin W. Marxe & David M. Greenhouse’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-40,500	Closed	-$10.9M	–	151
2014 Q2	$10.9M	Hold	40,500	–	–	1.38%	17
2014 Q1	$8.82M	Sell	40,500 -4,500	-10%	-$1.25M	0.98%	33
2013 Q4	$12.2M	Hold	45,000	–	–	1.3%	24
2013 Q3	$10.2M	Hold	45,000	–	–	1.26%	27
2013 Q2	$6.33M	Buy	+45,000	New	+$7.13M	0.85%	39

Other funds holding TTPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CPIM

Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's TTPH Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2014, closing a stake of 40,500 shares — an estimated $10.9M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in TTPH in Q2 2013 and held it in 5 quarters. The position peaked at $12.2M in Q4 2013. 73 funds tracked by Wall St. Rank hold TTPH as of Q3 2014.

Austin W. Marxe & David M. Greenhouse reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
Austin W. Marxe & David M. Greenhouse sold 40,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2014, an estimated $10.9M.
Austin W. Marxe & David M. Greenhouse first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
Austin W. Marxe & David M. Greenhouse's Tetraphase Pharmaceuticals, Inc. position peaked at $12.2M in Q4 2013.
73 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.